Refuse-to-Receive Actions – Lowest in 9 Months!
The Office of Generic Drugs’ update to the Activities Report of the Generic Drug Program for June 2017 (here) lists 6 Refuse-to-Receive (RTR) actions, the lowest for any moth this fiscal year. As a matter of fact, it is the lowest number of RTR actions since early in the GDUFA days when, in May 2013, […]